WHO ICTRP trial
Efficacy and safety of combined treatment with tranexamic acid and…
ChiCTR2000039879 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000039879 |
|---|---|
| Public title | Efficacy and safety of combined treatment with tranexamic acid and erythropoietin during surgery for intertrochanteric fractures |
| Scientific title | Efficacy and safety of combined treatment with tranexamic acid and erythropoietin during surgery for intertrochanteric fractures |
| Primary sponsor | The Affiliated Jiangning Hospital with Nanjing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | intertrochanteric fractures |
| Interventions | Group 1:tranexamic acid;Group 2:tranexamic acid and erythropoietin;Group 3:Nil |
| Registration date | Nov 13, 2020 |
| Target size | Group 1:50;Group 2:50;Group 3:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: